William Aird: Understanding the Ferritin Surge After IV Iron
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
”IV Iron and Ferritin
I recently posted a question about the spike in serum ferritin after IV iron. It can shoot from <10 to >1000, yet transferrin saturation (TSAT) only rises to normal — it barely moves.
What’s going on? This is macrophage physiology in action.
Step 1 – Uptake
IV iron–carbohydrate complexes (e.g., iron dextran) are endocytosed by macrophages in the liver, spleen, and marrow. Inside, the iron is released and floods the labile Fe²⁺ pool, the cell’s internal “iron bank.”
Step 2 – Ferritin synthesis explodes
- High intracellular Fe²⁺ flips the IRP–IRE switch, unleashing translational ferritin synthesis.
- Cytokines add a transcriptional boost.
- Ferritin production ↑↑ → serum ferritin rises via a regulated, non-classical secretion pathway.
Step 3 – The lab pattern
During the first 1–3 weeks after infusion:
- Ferritin ↑↑ (macrophage storage + secretion)
- TSAT ↑ to normal (as a small fraction of iron slowly transfers to transferrin)
Step 3 (cont’d)
Fe release is slow, because hepcidin levels rise after IV iron, throttling ferroportin and keeping iron temporarily trapped in macrophages (only a slow trickle of iron is exported via ferroportin into the bloodstream). This is redistribution, not overload.
Step 4 – Resolution
- As macrophages slowly export iron via ferroportin, their intracellular iron falls. The IRP–IRE system re-engages, ferritin synthesis drops, cytokine signals fade.
- Serum ferritin settles to a new, steady level.
Bottom line:
Ferritin spikes after IV iron because:
- Macrophages are suddenly iron-loaded → ↑ ferritin translation
- Cytokines transiently ↑ transcription
- Ferritin is secreted into plasma
As iron normalizes, ferritin synthesis and secretion taper.
Clinical takeaway: If you see ferritin >1000 and TSAT merely normal after IV iron, think macrophage response, not iron overload. Ferritin is telling you iron has arrived; it just hasn’t moved on yet.”

Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp
